Bill Title: Prohibits a manufacturer or wholesale distributor from engaging in unrestrained price increases in the sale of an essential off-patent or generic drug

Sponsorship: Partisan Bill (Republican 1)

Status: (Introduced - Dead) 2018-03-21 - Read by title, under the rules, referred to the Committee on Health and Welfare. [HB710 Detail]

Text: Latest bill text (Introduced) [PDF]

---

Voting Records

Chamber	Vote	Date	Yea	Nay	NV	Abs	Total	Result	Source	View
No roll call record information currently on file.

States not producing parsable votes may be available as images in Supplemental Documents.